J9030 — Bcg live intravesical instillation, 1 mg
J9030 is a HCPCS Level II code for bcg live intravesical instillation, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
Medically Unlikely Edits — units per day
The most units of J9030 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.
- practitioner
- 50 units MAI 3 — Date of Service Edit: Clinical · Prescribing Information
- outpatient
- 50 units MAI 3 — Date of Service Edit: Clinical · Prescribing Information
- DME supplier
- 0 — never payable MAI 3 — Date of Service Edit: Clinical · CMS Policy
The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.
The CMS record for J9030
- Long descriptor
- Bcg live intravesical instillation, 1 mg
- Short descriptor
- Bcg live intravesical 1mg
- Added
- July 1, 2019
- BETOS
- O1D
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9030
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9030 is not quite right, the correct code is very often within a few positions of it.
- J9022Injection, atezolizumab, 10 mg
- J9023Injection, avelumab, 10 mg
- J9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025Injection, azacitidine, 1 mg
- J9026Injection, tarlatamab-dlle, 1 mg
- J9027Injection, clofarabine, 1 mg
- J9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- J9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
- J9031Bcg (intravesical) per instillationterminated
- J9032Injection, belinostat, 10 mg
- J9033Injection, bendamustine hydrochloride, 1 mg
- J9034Injection, bendamustine hcl (bendeka), 1 mg
- J9035Injection, bevacizumab, 10 mg
- J9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
- J9037Injection, belantamab mafodotin-blmf, 0.5 mgterminated
- J9038Injection, axatilimab-csfr, 0.1 mg
Questions about J9030
What is HCPCS code J9030?
J9030 is a HCPCS Level II code for bcg live intravesical instillation, 1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9030?
The CMS HCPCS file marks J9030 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
How is J9030 paid under the physician fee schedule?
J9030 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).